Works matching IS 09147187 AND DT 2025 AND VI 39 AND IP 7

Results: 10

Comparative voxel-based dosimetry with pre-treatment Tc-99m SPECT/CT and post-treatment Y-90 PET/MRI for radioembolization with Y-90 microspheres.

Published in:

Annals of Nuclear Medicine, 2025, v. 39, n. 7, p. 716, doi. 10.1007/s12149-025-02052-5

By:

Demir, Burak;
Kucuk, Nuriye Ozlem;
Soydal, Cigdem;
Celebioglu, Emre Can;
Inal, Gizem;
Dursun, Ecenur;
Bilgic, Mehmet Sadık;
Kuru Oz, Digdem;
Elhan, Atilla Halil;
Kir, Kemal Metin

Publication type:

Article

Pre-treatment 111In-pentetreotide SPECT/CT vs. baseline 177Lu-DOTATATE SPECT/CT: are there differences in lesion uptake and detectability?

Published in:

Annals of Nuclear Medicine, 2025, v. 39, n. 7, p. 747, doi. 10.1007/s12149-025-02050-7

By:

Hotta, Masatoshi;
Horikawa, Daisuke;
Kurihara, Keiichi;
Ohashi, Shuhei;
Saito, Kaori;
Inagaki, Fuyuki

Publication type:

Article

Development and validation of a nomogram for predicting bone marrow involvement in lymphoma patients based on 18F-FDG PET radiomics and clinical factors.

Published in:

Annals of Nuclear Medicine, 2025, v. 39, n. 7, p. 663, doi. 10.1007/s12149-025-02041-8

By:

Lu, Denglu;
Zhu, Xinyu;
Mu, Xingyu;
Huang, Xiaoqi;
Wei, Feng;
Qin, Lilan;
Liu, Qixin;
Fu, Wei;
Deng, Yanyun

Publication type:

Article

Elapsed time changes of the brain radiopharmaceutical accumulation of the amyloid PET examination using 18F-flutemetamol.

Published in:

Annals of Nuclear Medicine, 2025, v. 39, n. 7, p. 732, doi. 10.1007/s12149-025-02046-3

By:

Takemoto, Shota;
Onuki, Koji;
Tanimoto, Keiko;
Taniguchi, Masaho;
Suero, Takako;
Okamoto, Mio;
Kimura, Satoshi;
Osawa, Monami;
Takeshige-Amano, Haruka;
Nishikawa, Noriko;
Aoki, Shigeki;
Kuwatsuru, Ryohei;
Hattori, Nobutaka;
Murakami, Koji

Publication type:

Article

Factors and predictors affecting late external dose rates and isolation period in patients after lutetium-177-labeled DOTA-Tyr3-octreotate treatment for neuroendocrine tumors.

Published in:

Annals of Nuclear Medicine, 2025, v. 39, n. 7, p. 696, doi. 10.1007/s12149-025-02044-5

By:

Wakabayashi, Naoto;
Watanabe, Shiro;
Takeuchi, Satoshi;
Tsuchikawa, Takahiro;
Munakata, Yamato;
Hirata, Kenji;
Kimura, Rina;
Takenaka, Junki;
Ishii, Hiroshi;
Kudo, Kohsuke

Publication type:

Article

Analysis of the best time-point for 18F-FDG PET/CT delayed imaging in patients of small colorectal cancer liver metastasis with hypothyroidism based on diagnostic efficacy and image standardized uptake values.

Published in:

Annals of Nuclear Medicine, 2025, v. 39, n. 7, p. 707, doi. 10.1007/s12149-025-02045-4

By:

Pei, Yusong;
Tong, Yanan;
Wang, Zhiguo;
Qiao, Xinxin;
Liu, Yanqing;
Zhang, Guoxu

Publication type:

Article

Blood and bone marrow dosimetry for thyroid cancer patients prepared with rhTSH injection.

Published in:

Annals of Nuclear Medicine, 2025, v. 39, n. 7, p. 676, doi. 10.1007/s12149-025-02042-7

By:

Al Jabri, Amna Juma;
Cooke, Jennie;
Cournane, Seán;
Healy, Marie-Louise

Publication type:

Article

Physiological bio-distribution of 68Ga-DOTA-TATE in pediatric patients.

Published in:

Annals of Nuclear Medicine, 2025, v. 39, n. 7, p. 650, doi. 10.1007/s12149-025-02040-9

By:

Filizoglu, Nuh;
Ozguven, Salih;
Kesim, Selin;
Oksuzoglu, Kevser;
Caglıyan, Feyza;
Ones, Tunc;
Dede, Fuat;
Turoglu, Halil Turgut;
Erdil, Tanju Yusuf

Publication type:

Article

Metabolic tumor parameters on 18F-FDG PET/CT can predict the expression of PD-L1 and prognosis in patients with fumarate hydratase-deficient renal cell carcinoma.

Published in:

Annals of Nuclear Medicine, 2025, v. 39, n. 7, p. 641, doi. 10.1007/s12149-025-02039-2

By:

Huang, Shuhui;
Zhang, Yaowen;
Zhang, Wei;
Tian, Tian;
Dai, Hongyuan;
Qi, Mengfang;
Su, Minggang;
Zeng, Hao;
Huang, Rui

Publication type:

Article

Low-iodine diet: what to eat and avoid before iodine-131 procedures?

Published in:

Annals of Nuclear Medicine, 2025, v. 39, n. 7, p. 687, doi. 10.1007/s12149-025-02043-6

By:

Silva, Gabriela O.;
Romeiro, Fernando G.;
Moriguchi, Sonia Marta;
Mazeto, Gláucia Maria F. S.;
Koga, Katia H.

Publication type:

Article

Works matching IS 09147187 AND DT 2025 AND VI 39 AND IP 7

Comparative voxel-based dosimetry with pre-treatment Tc-99m SPECT/CT and post-treatment Y-90 PET/MRI for radioembolization with Y-90 microspheres.

Pre-treatment <sup>111</sup>In-pentetreotide SPECT/CT vs. baseline <sup>177</sup>Lu-DOTATATE SPECT/CT: are there differences in lesion uptake and detectability?

Development and validation of a nomogram for predicting bone marrow involvement in lymphoma patients based on <sup>18</sup>F-FDG PET radiomics and clinical factors.

Elapsed time changes of the brain radiopharmaceutical accumulation of the amyloid PET examination using <sup>18</sup>F-flutemetamol.

Factors and predictors affecting late external dose rates and isolation period in patients after lutetium-177-labeled DOTA-Tyr3-octreotate treatment for neuroendocrine tumors.

Analysis of the best time-point for 18F-FDG PET/CT delayed imaging in patients of small colorectal cancer liver metastasis with hypothyroidism based on diagnostic efficacy and image standardized uptake values.

Blood and bone marrow dosimetry for thyroid cancer patients prepared with rhTSH injection.

Physiological bio-distribution of <sup>68</sup>Ga-DOTA-TATE in pediatric patients.

Metabolic tumor parameters on <sup>18</sup>F-FDG PET/CT can predict the expression of PD-L1 and prognosis in patients with fumarate hydratase-deficient renal cell carcinoma.

Low-iodine diet: what to eat and avoid before iodine-131 procedures?